| Bienvenida et al. |
Evaluation and Implementation of Low-Risk, High Volume Medication Autoverification in the Emergency Department
|
| Burdick et al. |
Standardization of DOAC Management Across a Health System
|
| Cua et al. |
Evaluation of Itraconazole, Posaconazole, and Voriconazole Post-Load Serum Concentrations to Estimate Steady-State Levels
|
| Fahey et al. |
Don’t Go Breaking My Heart: Optimization of Pharmacist Monitoring for Cancer Treatment Associated Cardiotoxicities
|
| Garmoe et al. |
Implementation and Impact of Pharmacist-Led Antiseizure Drug (ASD) Management Protocol
|
| Hillis et al. |
Optimization of Pharmacist-Led Oral Chemotherapy Outreach Using a Risk-Stratification Scoring Tool
|
| Imburgia et al. |
Review of Tobramycin Dosing in Pediatric Patients With Cystic Fibrosis
|
| Klatt et al. |
Increasing Possession of Naloxone by Cancer Patients on Opioids
|
| Kroll et al. |
Creation of National Antimicrobial Utilization Benchmarking Report and Validation of the Vizient CDB-RM Database
|
| Nachreiner et al. |
Optimization of a Pharmacist-Led Venous Thromboembolism Prophylaxis Program
|
| Przybylski et al. |
Development and Implementation of Expanded Pharmacist Involvement on UW Health’s Personalized Medicine Molecular Tumor Board
|
| Schmidt et al. |
Beyond Benzodiazepines: Protocol for Alcohol Withdrawal in the Intensive Care Unit
|
| Shu et al. |
Pharmacy Productivity Monitoring Metric Development and Refinement
|
| Stewart et al. |
Development and Implementation of Medication Preference List Management Processes in Primary Care
|
| Stiener et al. |
Implementation and Evaluation of an Outpatient Pharmacist-Led Immunosuppression Dosing Delegation Protocol in Stem Cell Transplant Recipients
|
| Wimmer et al. |
Evaluation and Implementation of a Pain, Agitation, and Delirium Protocol in Post-Surgical Cardiothoracic Patients
|
| Wong et al. |
Impact of Pharmacist Antiviral Stewardship on the Management of Cytomegalovirus Preemptive Monitoring on Prophylaxis Success
|
| Wynes et al. |
Development of a Pain, Agitation and Delirium Treatment Guideline in the Pediatric Intensive Care Unit
|
